No products in the cart.
MODULE 22: THE HOSPITAL ECOSYSTEM
Section 1.2: Direct & Inter-facility Transfers: The Scheduled Arrivals
Moving from reactive emergency response to proactive medication investigation.
SECTION 1.2
Direct & Inter-facility Transfers: The Scheduled Arrivals
Moving from reactive emergency response to proactive medication investigation.
1.2.1 The “Why”: Bypassing the ED for Planned Admissions or Higher Levels of Care
If the Emergency Department is the chaotic, unscheduled front door, think of direct and inter-facility transfers as the scheduled, and supposedly more organized, side entrances. These are patients who bypass the ED for a variety of reasons. Their arrival is planned, their destination within the hospital is often pre-determined, and there is an assumption that their clinical information will arrive with them in a neat, orderly package. As a pharmacist, you must immediately discard this assumption. The potential for catastrophic medication errors during these transitions is arguably even higher than for patients arriving through the ED.
Why? The illusion of order. In the ED, everyone is on high alert, and a complete medication history is built from the ground up. With transfers, there’s a dangerous tendency to accept the provided paperwork—the transfer MAR, the discharge summary from the outside hospital (OSH)—as the source of truth. This is a critical error. These documents are often riddled with inaccuracies, omissions, and outdated information. The “Why” of the pharmacist’s role here is to serve as the ultimate quality assurance checkpoint, to distrust and verify every piece of information, and to reconstruct the patient’s medication story with forensic precision before any incorrect orders are continued or initiated.
Common Transfer Scenarios & Their Inherent Risks
| Transfer Type | Description | Primary Medication Safety Risk |
|---|---|---|
| Direct Admission from Clinic | A patient is seen by their specialist (e.g., oncologist, cardiologist) who determines they require immediate admission. The clinic calls the hospital, arranges a bed, and sends the patient directly to the inpatient unit. | Information Gap. The clinic’s medication list may be perfect, but it often lacks information on adherence, recent changes made by other providers, or PRN medications. The focus is on the acute problem, and the full medication picture can be overlooked. |
| Inter-facility Transfer (Higher Level of Care) | A patient at a smaller community hospital or rural facility requires specialized care (e.g., neurosurgery, ECMO, burn unit) only available at your larger tertiary care center. | “Lost in Translation.” The transferring hospital’s EHR is different from yours. MARs are printed, faxed, or verbally reported, leading to transcription errors, missing information (especially for complex infusions), and confusion about what was last administered and when. |
| Transfer from SNF/LTAC/Rehab | A patient at a Skilled Nursing Facility (SNF), Long-Term Acute Care (LTAC), or rehabilitation center develops an acute condition (e.g., pneumonia, sepsis) requiring hospitalization. | Outdated & Incomplete Records. These facilities often operate with paper MARs. The records that arrive with the patient can be days old, incomplete, or contain handwritten notes that are illegible. There is a very high risk of missing critical medications like anticoagulants or insulin. |
1.2.2 The Pharmacist’s Role: Proactive Medication Investigator
Your role with a transfer patient is fundamentally different from that in the ED. You are shifting from a reactive emergency responder to a proactive, methodical investigator. The pace may be slightly less frantic, but the cognitive load is higher. You are not just taking a history; you are auditing a case file, looking for clues, identifying inconsistencies, and building a case for the safest and most accurate medication regimen possible. This requires a new set of masteries.
Mastery 1: Deconstructing the Transfer Medication Record
The transfer Medication Administration Record (MAR) or medication list is your primary piece of evidence, and it must be treated with extreme skepticism. Your first step is to perform a systematic review, looking for common red flags that signal a high likelihood of error. Your retail experience in spotting problematic prescriptions is directly applicable here.
Masterclass Table: Red Flags on Transfer Medication Records
| Red Flag | Example | Why It’s a Problem | Pharmacist’s Investigative Action |
|---|---|---|---|
| The Vague “Resume Home Meds” Order | A physician’s admission order simply states: “Resume all home medications.” | This is the most dangerous order in hospital medicine. It delegates the entire medication reconciliation process to the nurse and pharmacist without a formal, verified list. It is a recipe for disaster and is forbidden in most hospitals, but still appears. | STOP. Do not proceed. Immediately contact the provider. State clearly: “I cannot safely verify an order to ‘resume home meds.’ I am completing a full medication reconciliation now and will have specific orders for you to sign shortly.” |
| Ambiguous Frequency or Instructions | “Warfarin 5 mg daily” (no indication or INR goal). “Insulin sliding scale” (without the scale specified). “Tylenol PRN.” | These orders lack the critical parameters for safe administration. A nurse cannot act on them, and they introduce guesswork. | Call the transferring facility/provider. “I’m clarifying the warfarin order. What is the patient’s target INR range?” or “Can you please provide the parameters for the insulin sliding scale you were using?” |
| Therapeutic Duplication | The list includes both enoxaparin 40 mg daily AND apixaban 5 mg BID. The patient is on an ACE inhibitor and an ARB. | This often happens when new medications are started at one facility without formally discontinuing the old ones on the MAR. It’s a classic copy-paste error. | This requires a call to a human. “The transfer MAR lists both enoxaparin and apixaban. Can you confirm which one the patient was actually receiving and when the last dose was given?” |
| Missing High-Risk Medications | A patient with a history of seizures has no anti-epileptics listed. A patient with a mechanical heart valve has no anticoagulant listed. | This is a five-alarm fire. It’s highly likely an omission that could lead to significant harm (status epilepticus, valve thrombosis) if not corrected immediately. | This is your top priority. Use all your detective tools: call the family, call the retail pharmacy, call the provider. You must determine if this medication was intentionally held or accidentally omitted. |
Mastery 2: The Art of the Clarification Call
As a retail pharmacist, you are an expert at making clarification calls to prescribers. This skill is now elevated to a new level. Calling the nurse or pharmacist at the transferring facility is often the only way to get the real story. Success depends on being prepared, efficient, and knowing exactly what to ask.
The Pharmacist’s Transfer Call Checklist
Before you pick up the phone, have the patient’s chart and the transfer documents in front of you. Introduce yourself clearly (“Hello, this is [Your Name], a pharmacist at [Your Hospital]. I’m calling about [Patient Name], who was just transferred to our facility.”). Then, get straight to the point:
- High-Risk Meds First: “I want to confirm the anticoagulation plan first. Your MAR shows apixaban. Can you tell me the exact date and time of the last dose they received?”
- Insulin Confirmation: “For their insulin, the MAR lists Lantus 20 units daily. Can you confirm that’s the current dose and tell me when their last injection was?”
- PRN Specifics: “I see they have an order for PRN oxycodone. Can you tell me how frequently they have actually been requiring it in the last 24-48 hours?”
- Recent Changes: “Were there any medication changes made in the last 24 hours that might not be on this printed MAR?”
- The Open-Ended Closer: “Is there anything else I should know about this patient’s medications that isn’t obvious from the paperwork?”
Mastery 3: Bridging High-Risk Medication Gaps
Certain medications carry an outsized risk for error during transfers. As the investigator, you must place these under special scrutiny. Your job is to ensure there is no interruption in critical therapy and no accidental duplication or overdose.
The Golden Rule of Transfers: “When in doubt, HOLD.”
If you cannot definitively confirm the last dose of a critical medication like an anticoagulant or a long-acting opioid, the safest initial action is to hold the next dose and immediately contact the admitting physician. It is far safer to miss one dose while you investigate than to accidentally double-dose a patient with apixaban or fentanyl. Communicate your reasoning clearly: “Dr. Smith, I cannot verify the last dose of the patient’s Xarelto from the SNF. To prevent a potential double-dose, I am recommending we hold the evening dose and re-evaluate in the morning once we have more information.” This is safe, defensible, and a hallmark of a professional pharmacist.
Retail Pharmacist Analogy: The Pharmacy Transfer Investigation
A Deep Dive into the Analogy
You receive a call from a new patient who wants to transfer all their prescriptions from a small, independent pharmacy across town. They hand you a handwritten list of ten medications. This list is the transfer MAR. Your immediate professional instinct is not to trust it, but to investigate it.
You see “blood pressure pill” and “water pill” written on the list. These are your ambiguous orders. You see “Xanax as needed” without a quantity or frequency. That’s your incomplete PRN order. You notice the list includes both lisinopril and losartan. That’s your therapeutic duplication. Most alarmingly, the patient tells you they have A-Fib, but you don’t see an anticoagulant on the list at all. This is your critical omission.
You don’t just start typing what’s on the list. You pick up the phone and call the other pharmacy. This is your clarification call. You speak pharmacist-to-pharmacist. “Hi, this is [Your Name] from [Your Pharmacy]. I have a mutual patient, [Patient Name], who is transferring here. I have a list, but I need to confirm a few things.”
You go down the list with the other pharmacist. You confirm the exact name and sig of the “blood pressure pill” (it’s amlodipine 10 mg). You find out the “water pill” was discontinued a month ago. You confirm the Xanax was filled three months ago for only 10 tablets and likely isn’t a chronic medication. You discover the losartan was an old prescription, and the patient is, in fact, only taking lisinopril. Most importantly, you ask, “I don’t see an anticoagulant on here, but the patient mentioned A-Fib.” The other pharmacist checks their records. “Oh, wow, you’re right. They get their Eliquis through a specialty mail-order pharmacy. We don’t fill that here.”
You just saved that patient from a potential stroke. The process you just followed—skepticism, investigation, direct communication with the source, and a focus on high-risk medications—is the exact workflow of a hospital pharmacist managing an inter-facility transfer. You already have the skills; you are now just applying them in a new, even higher-stakes environment.
